BMO Capital Markets' Evan Seigerman: I'm encouraged by Pfizer raising 2025 profit outlook

Fizer shares are gaining this morning, up nearly 5% after beating earnings estimates on the top and bottom line. The company raising its fullear earnings guidance. Joining us now is managing director and head of healthcare research Evan David Seagerman.Thank you for being here, David. Um, so they hiked their forecast despite President Trump's calls to lower drug prices as well as uh tariffs on pharmaceuticals imported into the country, potential uh potentially more tariffs to come. Uh, do you think these po ...